Data as of Dec 19
| +0.22 / +7.21%|
The 4 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 8.75, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +167.58% increase from the last price of 3.27.
The current consensus among 4 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.